ExploreWatchlistsPricing
  1. JP-listed companies
  2. VITAL KSK HOLDINGS,INC.
  3. Financials
  4. Cost of revenue

VITAL KSK HOLDINGS,INC. (3151)

Market cap
¥78.3B
P/E ratio
9.9x
Vital KSK Holdings distributes pharmaceuticals to hospitals, pharmacies and veterinary practices while operating community pharmacies and healthcare services across Japan.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 2025551,155+2.22%
Mar 31, 2024539,179+0.82%
Mar 31, 2023534,809+0.29%
Mar 31, 2022533,272+6.90%
Mar 31, 2021498,839-3.57%
Mar 31, 2020517,282+0.40%
Mar 31, 2019515,226-1.26%
Mar 31, 2018521,809-2.73%
Mar 31, 2017536,478-6.22%
Mar 31, 2016572,031+12.95%
Mar 31, 2015506,453

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat